Chlophedianol, dexchlorpheniramine, and pseudoephedrine and Daclizumab Subcutaneous
Determining the interaction of Chlophedianol, dexchlorpheniramine, and pseudoephedrine and Daclizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: chlophedianol / dexchlorpheniramine / pseudoephedrine
Brand name: Panatuss PED, Vanacof, Panatuss PED Drops
Synonyms: n.a.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Dacogen
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Dacomitinib
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Dactinomycin
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Dactinomycin Injection
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Dactinomycin Intravenous
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Daklinza
- Daclizumab Subcutaneous-Chlophedianol, Dexchlorpheniramine, and Pseudoephedrine Drops
- Daclizumab Subcutaneous-Chlophedianol, Dexchlorpheniramine, and Pseudoephedrine Liquid
- Daclizumab Subcutaneous-Chlophedianol, Guaifenesin, and Phenylephrine Liquid
- Daclizumab Subcutaneous-Chlophedianol, phenylephrine, and pyrilamine
- Daclizumab Subcutaneous-Chlophedianol/Dexbrompheniramine/Phenylephrine Liquid
- Daclizumab Subcutaneous-Chlophedianol/Guaifenesin Liquid